PubRank

Andrea Fuchsbichler

Author PubWeight™ 47.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002 3.80
2 Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002 2.64
3 Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004 2.02
4 Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 2009 1.87
5 Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol 2003 1.85
6 Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005 1.84
7 Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003 1.79
8 Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology 2009 1.72
9 A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007 1.70
10 Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 2005 1.64
11 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2006 1.54
12 Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice. Liver Int 2008 1.52
13 Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 2005 1.46
14 Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 2003 1.41
15 Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. Am J Pathol 2006 1.30
16 Mallory body--a disease-associated type of sequestosome. Hepatology 2002 1.28
17 Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 2005 1.22
18 Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis. Gastroenterology 2010 1.17
19 The keratin cytoskeleton in liver diseases. J Pathol 2004 1.15
20 Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int 2005 1.10
21 Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol 2002 1.03
22 In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62. Hepatology 2007 1.02
23 Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiol Gastrointest Liver Physiol 2005 0.96
24 Interaction of stress proteins with misfolded keratins. Eur J Cell Biol 2005 0.93
25 Cytokeratins as targets for bile acid-induced toxicity. Am J Pathol 2002 0.91
26 Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. J Hepatol 2003 0.89
27 Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis. Trop Med Int Health 2009 0.88
28 Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol 2002 0.86
29 Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers. Am J Physiol Gastrointest Liver Physiol 2005 0.85
30 Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci 2004 0.85
31 Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 2004 0.84
32 Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress. Drug Metab Dispos 2007 0.82
33 Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. Hepatology 2010 0.82
34 The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice. Hepatology 2009 0.78
35 Intermediate filament protein inclusions. Methods Cell Biol 2004 0.77
36 Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver Int 2009 0.77
37 p62 protein is expressed in pancreatic beta cells. J Pathol 2005 0.75